- 1. Q1 FY2014 earnings investor/analyst call October 31, 2013
Copyright 2013, Cardinal Health. All rights reserved. CARDINAL
HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are
trademarks or registered trademarks of Cardinal Health. All other
marks are the property of their respective owners.
2. Forward-looking statements and GAAP reconciliation Cautions
Concerning Forward-Looking Statements This presentation contains
forward-looking statements addressing expectations, prospects,
estimates and other matters that are dependent upon future events
or developments. These statements may be identified by words such
as "expect," "anticipate," "intend," "plan," "believe," "will,"
"should," "could," "would," "project," "continue," "likely," and
similar expressions, and include statements reflecting future
results or guidance, statements of outlook and expense accruals.
These matters are subject to risks and uncertainties that could
cause actual results to differ materially from those projected,
anticipated or implied. These risks and uncertainties include
competitive pressures in Cardinal Health's various lines of
business; the ability to achieve the expected benefits from the
AssuraMed acquisition; the timing of generic and branded
pharmaceutical introductions and the frequency or rate of
pharmaceutical price appreciation or deflation; the non-renewal,
early termination or a default under one or more key customer or
supplier arrangements or changes to the terms of or level of
purchases under those arrangements; uncertainties due to government
health care reform including federal health care reform
legislation; changes in the distribution patterns or reimbursement
rates for health care products and services; and the effects of any
investigation or action by any regulatory authority; changes in the
cost of commodities such as oil-based resins, cotton, latex and
diesel fuel. Cardinal Health is subject to additional risks and
uncertainties described in Cardinal Health's Form 10-K, Form 10-Q
and Form 8-K reports and exhibits to those reports. This
presentation reflects management's views as of October 31, 2013.
Except to the extent required by applicable law, Cardinal Health
undertakes no obligation to update or revise any forwardlooking
statement. Cardinal Health provides definitions and reconciling
information at the end of this presentation and on its Investors
page at www.cardinalhealth.com. An audio replay of the conference
call will be available on the Investors page at
www.cardinalhealth.com.2 Copyright 2013, Cardinal Health. All
rights reserved. CARDINAL HEALTH, the Cardinal Health LOGO and
ESSENTIAL TO CARE are trademarks or registered trademarks of
Cardinal Health. All other marks are the property of their
respective owners. 3. Q1 FY2014 financial summary GAAP Basis ($M)
Revenue % change Operating earnings % change Ratio to revenue
Earnings from continuing ops % change Ratio to revenue Diluted EPS
from continuing ops % changeQ1 FY13 $25,889 (3)% $457 11% 1.76%
$272 15% 1.05% $0.79 16%Operating cash flow3Q1 FY14 $24,523 (5)%
$471 3% 1.92% $340 25% 1.38% $0.99 25% Q1 FY14 $951Q1 FY13 $568
Copyright 2013, Cardinal Health. All rights reserved. CARDINAL
HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are
trademarks or registered trademarks of Cardinal Health. All other
marks are the property of their respective owners.Non-GAAP Basis
($M) Q1 FY14Q1 FY13$532 13% 2.17% $378 35% 1.54% $1.10 36%$469 6%
1.81% $281 9% 1.08% $0.81 11% 4. Q1 FY2014 Pharmaceutical segment
business analysis Q1 FY14 ($M) Revenue Segment profit Segment
profit marginQ1 FY13 ($M)%
Change$21,813$23,498(7)%$433$4008%1.99%1.70%Highlights: Revenue
decreased 7% vs. last year driven by the previously announced
expiration of the Express Scripts contract on September 30, 2012
and the Walgreens contract on August 31, 2013. The decline was
partially offset by volume growth from new and existing customers
Segment profit increased 8%, demonstrating balance across the
businesses, with both generic and branded programs showing strong
performance Expanded segment profit margin by 29bpsThe sum of the
components may not equal the total due to rounding4 Copyright 2013,
Cardinal Health. All rights reserved. CARDINAL HEALTH, the Cardinal
Health LOGO and ESSENTIAL TO CARE are trademarks or registered
trademarks of Cardinal Health. All other marks are the property of
their respective owners. 5. Q1 FY2014 Medical segment business
analysis Q1 FY14 ($M) Revenue Segment profit Segment profit
marginQ1 FY13 ($M)%
Change$2,711$2,39313%$106$7443%3.92%3.11%Highlights: Revenue
increased primarily due to the recent AssuraMed acquisition. Also
realized strong growth in strategic hospital network accounts
Segment profit up 43%, driven by: AssuraMed acquisition Planned
efficiency initiatives Performance of preferred products portfolio
Expanded segment profit margin by 82bpsThe sum of the components
may not equal the total due to rounding5 Copyright 2013, Cardinal
Health. All rights reserved. CARDINAL HEALTH, the Cardinal Health
LOGO and ESSENTIAL TO CARE are trademarks or registered trademarks
of Cardinal Health. All other marks are the property of their
respective owners. 6. Q1 FY2014 GAAP to non-GAAP reconciliation Q1
FY 2014 Operating Earnings ($M) GAAP Restructuring and employee
severance Amortization and other acquisition-related costs1
Impairments and loss on disposal of assets Litigation
(recoveries)/charges, net Non-GAAP 1Q1 FY 2013Earnings from Diluted
EPS Operating Continuing from Continuing Earnings ($M) Operations
($M) OperationsEarnings from Diluted EPS Continuing from Continuing
Operations ($M) Operations$471 11$340 7$0.99 0.02$457 5$272 3$0.79
0.0149310.0928180.051 $5321 $378$1.101 (22) $4691 (13) $281(0.04)
$0.81Amortization of acquisition-related intangible assets included
in Amortization and other acquisition-related costs are as
follows:Amortization of acquisition-related intangible
assets$45$28$0.08The sum of the components may not equal the total
due to rounding6 Copyright 2013, Cardinal Health. All rights
reserved. CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL
TO CARE are trademarks or registered trademarks of Cardinal Health.
All other marks are the property of their respective
owners.$21$13$0.04 7. FY2014 outlook7 Copyright 2013, Cardinal
Health. All rights reserved. CARDINAL HEALTH, the Cardinal Health
LOGO and ESSENTIAL TO CARE are trademarks or registered trademarks
of Cardinal Health. All other marks are the property of their
respective owners. 8. Updated FY2014 financial expectations October
31, 2013FY2014 non-GAAP EPS from continuing operations:$3.62 -
$3.728 Copyright 2013, Cardinal Health. All rights reserved.
CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are
trademarks or registered trademarks of Cardinal Health. All other
marks are the property of their respective owners. 9. Updated FY14
corporate assumptions October 31, 2013 FY14 outlookFY13
actual343M344.5MInterest and other, net$140M - $150M$108MCapital
expenditures$245M - $265M$195M~$180M or ~$0.331$118M or
$0.2234.5-36%233.7%3Diluted weighted average shares
outstandingAmortization of acquisition-related intangible assets
Non-GAAP effective tax rate 1 2 39Includes only acquisitions closed
as of September 30, 2013 Represents annual rate. Expected to
fluctuate quarterly due to unique items affecting periods. Includes
$63M related to favorable settlements in Q1 FY14, which contributed
$0.18 to Non-GAAP EPS Includes $64M related to a favorable
settlement in Q3 FY13, which contributed $0.18 to Non-GAAP EPS
Copyright 2013, Cardinal Health. All rights reserved. CARDINAL
HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are
trademarks or registered trademarks of Cardinal Health. All other
marks are the property of their respective owners. 10. 10 Copyright
2013, Cardinal Health. All rights reserved. CARDINAL HEALTH, the
Cardinal Health LOGO and ESSENTIAL TO CARE are trademarks or
registered trademarks of Cardinal Health. All other marks are the
property of their respective owners. 11. Q1 FY2014 trailing five
quarters and GAAP to Non-GAAP reconciliation statements11 Copyright
2013, Cardinal Health. All rights reserved. CARDINAL HEALTH, the
Cardinal Health LOGO and ESSENTIAL TO CARE are trademarks or
registered trademarks of Cardinal Health. All other marks are the
property of their respective owners. 12. Q1 FY2014 segment analysis
Pharmaceutical segment Q1 FY13Q2 FY13Q3 FY13Q4 FY13Q1
FY1423,49822,74722,07022,78321,813400441498395433Q1 FY13Q2 FY13Q3
FY13Q4 FY13Q1 FY14Revenue ($M)2,3932,4872,4842,6972,711Segment
Profit ($M)7494100104106Revenue ($M)Segment Profit ($M)Medical
segment12 Copyright 2013, Cardinal Health. All rights reserved.
CARDINAL HEALTH, the Cardinal Health LOGO and ESSENTIAL TO CARE are
trademarks or registered trademarks of Cardinal Health. All other
marks are the property of their respective owners. 13. Cardinal
Health, Inc. and Subsidiaries GAAP / Non-GAAP Reconciliation(in
millions, except per common share amounts) GAAP Restructuring and
employee severance Amortization and other acquisition-related costs
Impairments and loss on disposal of assets Litigation
(recoveries)/charges, net Non-GAAPGAAP Restructuring and employee
severance Amortization and other acquisition-related costs
Impairments and loss on disposal of assets Litigation
(recoveries)/charges, net Non-GAAPOperating Earnings Before
Earnings Incom e Taxes Operating Grow th and Discontinued Earnings
Rate Operations $ 471 3% $ 442 11 11 49 49 1 1 $ 532 13 % $
503$$457 5 28 1 (22) 46911 % $6% $First Quarter 2014 Provision
Earnings Earnings from for from Continuing Incom e Continuing
Operations Taxes Operations Grow th Rate $ 102 $ 340 25 % 4 7 18 31
1 $ 124 $ 378 35 %439 $ 5 28 1 (22) 451 $The sum of the components
may not equal the total due to rounding. We apply varying tax rates
depending on the items nature and tax jurisdiction w here it is
incurred.First Quarter 2013 167 $ 272 2 3 10 18 1 (9) (13) 170 $
281Diluted EPS Diluted EPS from from Continuing Continuing
Operations Operations Grow th Rate $ 0.99 25 % 0.02 0.09 $ 1.10 36
%15 % $9% $0.79 0.01 0.05 (0.04) 0.8116 %11 % 14. Cardinal Health,
Inc. and Subsidiaries GAAP / Non-GAAP Reconciliation First Quarter
(in millions) GAAP return on equity Non-GAAP return on equity Net
earnings Restructuring and employee severance, net of tax, in
continuing operations Amortization and other acquisition-related
costs, net of tax, in continuing operations Impairments and loss on
disposal of assets, net of tax, in continuing operations Litigation
(recoveries)/charges, net, net of tax, in continuing operations
Adjusted net earnings AnnualizedTotal shareholders' equity Divided
by average shareholders' equity Non-GAAP return on equity2013 17.3
%2014 22.1 %$$ $$ $$339 7 31 1 378 1,512 First Quarter 2014 6,297
6,136 24.7 %We apply varying tax rates depending on the items
nature and tax jurisdiction w here it is incurred.$ $$Fourth
Quarter 2013 5,975$ $271 3 18 1 (13) 280 1,120 First Quarter 2013
6,281 6,263 17.9 %$Fourth Quarter 2012 6,244 15. Cardinal Health,
Inc. and Subsidiaries GAAP / Non-GAAP Reconciliation First Quarter
(in millions) GAAP effective tax rate from continuing operations 1
Non-GAAP effective tax rate from continuing operations Earnings
before income taxes and discontinued operations Restructuring and
employee severance Amortization and other acquisition-related costs
Impairments and loss on disposal of assets Litigation
(recoveries)/charges, net Adjusted earnings before income taxes and
discontinued operations Provision for income taxes Restructuring
and employee severance tax benefit Amortization and other
acquisition-related costs tax benefit Impairments and loss on
disposal of assets tax benefit Litigation (recoveries)/charges, net
tax expense Adjusted provision for income taxes2013 38.1 %2014 23.2
%$442 11 49 1 503$ $102 4 18 124$Non-GAAP effective tax rate from
continuing operations 1$439 5 28 1 (22) 451$ $167 2 10 (9) 170$37.8
%24.7 % First Quarter20132014 Debt to total capital Net debt to
capital Current portion of long-term obligations and other
short-term borrow ings Long-term obligations, less current portion
Debt Cash and equivalents Net debt Total shareholders' equity
Capital Net debt to capital 131 %38 %$ $ $ $190 3,693 3,883 (2,753)
1,130 6,297 7,427 15 %$ $ $ $471 2,408 2,879 (2,440) 439 6,281
6,720 7%The settlement of federal and state tax controversies
favorably impacted, for fiscal 2014 first quarter, both the
effective tax rate from continuing operations and nonGAAP effective
tax rate from continuing operations by 14.3 and 12.6 percentage
points, respectively. The fiscal 2014 first quarter non-GAAP
effective tax rate from continuing operations, excluding the impact
of the tax settlement, w ould have been 37.3%. We apply varying tax
rates depending on the items nature and tax jurisdiction w here it
is incurred. 16. Cardinal Health, Inc. and Subsidiaries GAAP /
Non-GAAP Reconciliation Fiscal Year 2013 62.3 %(in millions) GAAP
effective tax rate from continuing operations 1 Non-GAAP effective
tax rate from continuing operations Earnings/(loss) before income
taxes and discontinued operations Restructuring and employee
severance Amorization and other acquisition-related costs
Impairments and loss on disposal of assets Litigation
(recoveries)/charges, net Adjusted earnings before income taxes and
discontinued operations Provision for income taxes Restructuring
and employee severance tax benefit Amortization and other
acquisition-related costs tax benefit Impairments and loss on
disposal of assets tax benefit Litigation (recoveries)/charges, net
tax expense Adjusted provision for income taxes Non-GAAP effective
tax rate from continuing operations 1$$ $$888 71 158 859 (38) 1,938
553 27 52 37 (15) 654 33.7 %We apply varying tax rates depending on
the items nature and tax jurisdiction w here it is incurred. 1For
fiscal 2013, the revaluation of the deferred tax liability and
related interest on unrepatriated foreign earnings as a result of
an agreement w ith tax authorities reduced, for fiscal 2013, both
the effective tax rate from continuing operations and non-GAAP
effective tax rate from continuing operations by 7.2 and 3.3
percentage points, respectively. The fiscal 2013 non-GAAP effective
tax rate from continuing operations, excluding the impact of the
tax settlement, w ould have been 37.0%. 17. Cardinal Health, Inc.
and Subsidiaries GAAP / Non-GAAP Reconciliation First Quarter (in
millions) Distribution, selling, general and administrative
expenses Restructuring and employee severance Amortization and
other acquisition-related costs Impairments and loss on disposal of
assets Litigation (recoveries)/charges, net Total GAAP operating
expenses GAAP operating expense grow th rate Restructuring and
employee severance Amortization and other acquisition-related costs
Impairments and loss on disposal of assets Litigation
recoveries/(charges), net Total Non-GAAP operating expenses
Non-GAAP operating expense grow th rate20132014 $$$732 11 49 1 793
13.0 % (11) (49) (1) 732 6.1 %$$690 5 28 1 (22) 702$(5) (28) (1) 22
690 18. Cardinal Health, Inc. and Subsidiaries GAAP / Non-GAAP
Reconciliation First Quarter (in
millions)20132014Revenue$24,523$GAAP operating earnings
Restructuring and employee severance Amortization and other
acquisition-related costs Impairments and loss on disposal of
assets Litigation (recoveries)/charges, net Non-GAAP operating
earnings$471 11 49 1 532$GAAP operating earnings m argin rate
Non-GAAP operating earnings m argin rate$1.92 % 2.17 % 36bp$25,889
457 5 28 1 (22) 469 1.76 % 1.81 %The sum of the components may not
equal the total due to rounding. Forw ard-Looking Non-GAAP
Financial Measures We present non-GAAP earnings from continuing
operations and non-GAAP effective tax rate from continuing
operations (and presentations derived from these financial
measures, including per share calculations) on a forw ard-looking
basis. The most directly comparable forw ard-looking GAAP measures
are earnings from continuing operations and effective tax rate from
continuing operations. We are unable to provide a quantitative
reconciliation of these forw ard-looking non-GAAP measures to the
most directly comparable forw ard-looking GAAP measures because w e
cannot reliably forecast restructuring and employee severance,
amortization and other acquisition-related costs, impairments and
loss on disposal of assets and litigation (recoveries)/charges,
net, w hich are difficult to predict and estimate and are primarily
dependent on future events. Please note that the unavailable
reconciling items could significantly impact our future financial
results. 19. Cardinal Health, Inc. and Subsidiaries Schedule of
Notable Item s First Quarter (in millions, except per common share
amounts) Restructuring and employee severance Tax benefit
Restructuring and em ployee severance, net of tax20132014 $$(11) 4
(7)$(5) 2 (3)$(0.02)$(0.01)$$$(45) 17 (28)$(21) 8
(13)$(0.08)$(0.04)$(3)$(7)$1 (2)$2 (5)Decrease to diluted EPS from
continuing operations$(0.01)$(0.01)Total amortization and other
acquisition-related costs 1$(49)$(28)$Decrease to diluted EPS from
continuing operations Am ortization and Other Acquisition-Related
Costs Amortization of acquisition-related intangible assets Tax
benefit Am ortization of acquisition-related intangible assets, net
of tax Decrease to diluted EPS from continuing operations Other
acquisition-related costs Tax benefit Other acquisition-related
costs, net of taxTax benefit11018 1$(31)$(18)$(0.09)$(0.05)$$-$(1)
(1)Decrease to diluted EPS from continuing operations$-$-Litigation
recoveries/(charges), net Tax expense Litigation
recoveries/(charges), net, net of tax$$$(1) (1)22 (9) 13Increase to
diluted EPS from continuing operations$-$Total am ortization and
other acquisition-related costs, net of tax Decrease to diluted EPS
from continuing operations 1 Impairments and loss on disposal of
assets Tax benefit Im pairm ents and loss on disposal of assets,
net of taxWeighted-average num ber of diluted shares outstanding
1The sum of the components may not equal the total due to rounding.
We apply varying tax rates depending on the items nature and tax
jurisdiction w here it is incurred.$344$0.04 344 20. Cardinal
Health, Inc. and Subsidiaries Asset Managem ent Analysis First
Quarter 20132014 Debt to total capital Net debt to capital38 % 15 %
22.1 % 24.7 %Effective tax rate from continuing operations 1
Non-GAAP effective tax rate from continuing 1operations 117.3 %
17.9 %23.2 %Return on equity Non-GAAP return on equity31 % 7%38.1
%24.7 %37.8 %The settlement of federal and state tax controversies
favorably impacted, for fiscal 2014 first quarter, both the
effective tax rate from continuing operations and nonGAAP effective
tax rate from continuing operations by 14.3 and 12.6 percentage
points, respectively. The fiscal 2014 first quarter non-GAAP
effective tax rate from continuing operations, excluding the impact
of the tax settlement, w ould have been 37.3%. Refer to the
GAAP/Non-GAAP reconciliation for definitions and calculations
supporting the Non-GAAP balances. Given the expiration of our
pharmaceutical distribution contract w ith Walgreen Co. on August
31, 2013, w e do not believe that days sales outstanding, days
inventory on hand, days payable outstanding and net w orking
capital days provide meaningful measures of our w orking capital
performance in fiscal 2014 first quarter. 21. Cardinal Health, Inc.
and SubsidiariesDefinitions Debt: long-term obligations plus
short-term borrow ings. Debt to Total Capital: debt divided by
(debt plus total shareholders equity). Interest and Other, net:
other (income)/expense, net plus interest expense, net. Net Debt: a
Non-GAAP measure defined as debt minus (cash and equivalents). Net
Debt to Capital: a Non-GAAP measure defined as net debt divided by
(net debt plus total shareholders equity). Non-GAAP Diluted EPS
from Continuing Operations: non-GAAP earnings from continuing
operations divided by diluted w eighted-average shares outstanding.
Non-GAAP Earnings from Continuing Operations: earnings from
continuing operations excluding (1) restructuring and employee
severance1, (2) amortization and other acquisition-related costs 2,
(3) impairments and loss on disposal of assets 3 and (4) litigation
(recoveries)/charges, net4, each net of tax. Non-GAAP Effective Tax
Rate from Continuing Operations: (provision for income taxes
adjusted for (1) restructuring and employee severance, (2)
amortization and other acquisition-related costs, (3) impairments
and loss on disposal of assets and (4) litigation
(recoveries)/charges, net) divided by (earnings before income taxes
and discontinued operations adjusted for the same four items).
Non-GAAP Operating Earnings: operating earnings excluding (1)
restructuring and employee severance, (2) amortization and other
acquisition-related costs, (3) impairments and loss on disposal of
assets and (4) litigation (recoveries)/charges, net. Non-GAAP
Operating Earnings Margin Rate: current period non-GAAP operating
earnings divided by revenue. Non-GAAP Operating Expenses: operating
expenses excluding (1) restructuring and employee severance, (2)
amortization and other acquisition-related costs, (3) impairments
and loss on disposal of assets and (4) litigation
(recoveries)/charges, net. Non-GAAP Return on Equity: (annualized
net earnings excluding (1) restructuring and employee severance,
(2) amortization and other acquisition-related costs, (3)
impairments and loss on disposal of assets and (4) litigation
(recoveries)/charges, net, each net of tax) and divided by average
shareholders equity. Return on Equity: annualized net earnings
divided by average shareholders equity. Revenue Mix: segment
revenue divided by total segment revenue for all segments. Segm ent
Profit: segment revenue minus (segment cost of products sold and
segment distribution, selling, general and administrative
expenses). Segm ent Profit Margin: segment profit divided by
segment revenue. Segm ent Profit Mix: segment profit divided by
total segment profit for all segments. 1Programs w hereby Cardinal
Health fundamentally changes its operations such as closing and
consolidating facilities, moving manufacturing of a product to
another location, production or business process sourcing, employee
severance (including rationalizing headcount or other significant
changes in personnel) and realigning operations (including
substantial realignment of the management structure of a business
unit in response to changing market conditions).2Costs that consist
primarily of amortization of acquisition-related intangible assets,
transaction costs, integration costs and changes in the fair value
of contingent consideration obligations.3Asset impairments and
losses from the disposal of assets not eligible to be classified as
discontinued operations are classified w ithin impairments and loss
on disposal of assets w ithin the condensed consolidated statements
of earnings.4Loss contingencies related to litigation and
regulatory matters and income from favorable resolution of legal
matters.